Laser therapy capabilities using Multiwave Locked System in pulmonology

Introduction. Laser therapy is a pathogenetically justified method for treating diseases of the bronchopulmonary system. With the advent of the Multiwave Locked System (MLS therapy), which combines continuous (808 nm) and pulsed (905 nm) emission modes, the possibilities of laser therapy for bronchopulmonary diseases have expanded. The aim of this review is to present the capabilities of laser therapy using the Multiwave Locked System (MLS therapy) in pulmonology. Materials and methods. A literature search was conducted in the PubMed/MedLine and eLIBRARY databases for the period from 2010 to 2024. Results. The analysis of literature data showed that the use of MLS therapy in bronchopulmonary diseases is a justified and effective treatment method. The use of MLS therapy in the comprehensive medical rehabilitation of pulmonary patients not only provides pronounced anti-inflammatory, anti-edematous, analgesic, and immunomodulating effects, but also improves lung function, peripheral oxygen saturation, increases exercise tolerance, and prevents the development of fibrosis.